Form D · Biotechnology
Atia Vision, Inc.
Campbell, CA · CIK 0001735829
Offering snapshot reported Aug 22, 2022 · SEC filing
- Reported sold
- $28.7M Offering amount: $28.7M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $15K Reported outside-investor minimum
- First sale
- Jul 29, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 22, 2022 | Initial | $28,650,000 | No comparison | 10 | SEC filing |
| Nov 23, 2021 | Initial | $5,435,000 | No comparison | 12 | SEC filing |
| May 9, 2019 | Initial | $11,637,507 | No comparison | 21 | SEC filing |
| Nov 21, 2018 | Initial | $3,250,000 | No comparison | 5 | SEC filing |
| Apr 3, 2018 | Initial | $2,000,001 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-456466
Source: Form D, filed Aug 22, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Claudio Argento | Director |
| Henry Chen | Director |
| Bihua Chen | Director |
| Casey Gordon | Director |
| Mariam Maghribi | Director, Executive |
| Amr Salahieh | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
550 Division Street
Campbell, CA, 95008
Campbell, CA, 95008